Impact analysis of signals detected from spontaneous adverse drug reaction reporting data.
about
Dilemmas of the causality assessment tools in the diagnosis of adverse drug reactionsDrug-induced acute myocardial infarction: identifying 'prime suspects' from electronic healthcare records-based surveillance systemDevelopment of a combined system for identification and classification of adverse drug reactions: Alerts Based on ADR Causality and Severity (ABACUS).Improved statistical signal detection in pharmacovigilance by combining multiple strength-of-evidence aspects in vigiRank.Making the most of spontaneous adverse drug reaction reporting.Comparison of the safety of seven iodinated contrast media.Regulatory decision-making: are we getting it right?Decision making in drug safety-a literature review of criteria used to prioritize newly detected safety issues.Pharmacological prioritisation of signals of disproportionate reporting: proposal of an algorithm and pilot evaluation.What Is the Plural of a 'Yellow' Anecdote?Development of a novel regulatory pharmacovigilance prioritisation system: an evaluation of its performance at the UK Medicines and Healthcare products Regulatory Agency.Clinical perspectives in drug safety and adverse drug reactions.An Automated System Combining Safety Signal Detection and Prioritization from Healthcare Databases: A Pilot Study.Signal Detection for Recently Approved Products: Adapting and Evaluating Self-Controlled Case Series Method Using a US Claims and UK Electronic Medical Records Database.Descriptions of Adverse Drug Reactions Are Less Informative in Forums Than in the French Pharmacovigilance Database but Provide More Unexpected Reactions.
P2860
Q26743858-44DC1955-8770-418E-B01A-055D07EBF2F0Q28535919-8008D7EE-870F-4FAF-8426-6896A669F005Q33392383-7E56BC24-744E-4E00-B0D7-EE77F068298FQ34051874-F6FCD778-6F9A-418D-B0DE-416286FD8A31Q36447543-1C094C5D-115D-49F5-944C-E64E481D5EBFQ37378720-A881B417-F36B-46E8-A888-E016471E7C49Q38996482-561847D7-C4E0-42D9-899D-A1F1DC7CBB65Q39017851-5DC460CB-2568-4F54-9951-48ED1E57F88DQ43897779-12CB419F-3BAA-416B-9FC9-0F0B097F2C07Q44282365-742AC0BE-1470-4A62-9A94-26B7404AFECDQ45090307-1FEBF43F-EC94-43BD-A861-1052168BC431Q46975372-B08BCF64-C42C-413E-976E-D0DD8361EBF9Q47399072-440A8D9D-0AA5-4F73-9C49-EAF39ECA38E9Q47736466-2A76A627-2EFD-4915-A6B5-A444DAB74BB1Q55109854-7E11375C-B4F8-439B-A0D1-BBACC0AAB1FD
P2860
Impact analysis of signals detected from spontaneous adverse drug reaction reporting data.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Impact analysis of signals det ...... drug reaction reporting data.
@ast
Impact analysis of signals det ...... drug reaction reporting data.
@en
type
label
Impact analysis of signals det ...... drug reaction reporting data.
@ast
Impact analysis of signals det ...... drug reaction reporting data.
@en
prefLabel
Impact analysis of signals det ...... drug reaction reporting data.
@ast
Impact analysis of signals det ...... drug reaction reporting data.
@en
P2093
P1433
P1476
Impact analysis of signals det ...... drug reaction reporting data.
@en
P2093
Emma Heeley
Jane Moseley
Patrick Waller
P304
P356
10.2165/00002018-200528100-00002
P577
2005-01-01T00:00:00Z
P6179
1013401643